Abstract
Coronary heart disease (CHD) is the leading cause of death in the United States. The rate of CHD and CHD death varies across racial groups, with higher rates among black men and women than among white men and women. The development of CHD is promoted by major CHD risk factors—dyslipidemia, hypertension, and smoking. These risk factors are independently associated with CHD risk and are common among adults in the United States. Diabetes mellitus is also a significant contributor to CHD risk and is associated with risk of a CHD event equivalent to that conferred by the presence of prior CHD. Metabolic syndrome, a related condition, also confers a high risk for CHD as well as for the development of type 2 diabetes. Diabetes and metabolic syndrome are characterized by the presence of central obesity and insulin resistance, which result in dyslipidemia, hypertension, and cardiovascular derangements that promote CHD. Diabetes and metabolic syndrome illustrate the significance of risk factor clustering, which contributes to CHD risk through the additive effect of each risk factor. Diabetes, metabolic syndrome, and risk factor clustering in general are becoming more prevalent, which illustrates the need for better CHD prevention strategies aimed at risk factor control. The pathologic process associated with risk factor clustering also contributes to the higher CHD burden among black men and women, who have a higher prevalence of risk factor clustering and type 2 diabetes. Furthermore, despite having a higher CHD risk, black men and women are less likely to receive adequate treatment or control of risk factors, including dyslipidemia or hypertension. Eliminating disparities among population groups will thus require aggressive efforts focused on risk assessment, guideline adherence, and risk factor control in populations in need.
Full Text
The Full Text of this article is available as a PDF (46.9 KB).
References
- 1. Arias E, Anderson RN, Hsiang‐Ching K, Murphy SL, Kochanek KD: Deaths: Final data for 2001, National Vital Statistics Report, 52, No. 3, Hyattsville, Maryland: National Center for Health Statistics, 2003. [PubMed]
- 2. American Heart Association Statistical Fact Sheet‐Populations : African‐Americans and Cardiovascular Disease Statistics. American Heart Association, 2004. [Google Scholar]
- 3. American Heart Association Statistical Fact Sheet‐Populations : Whites and Cardiovascular Disease Statistics. American Heart Association, 2004. [Google Scholar]
- 4. Cooper R, Cutler J, Desvigne‐Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T: Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: Findings of the National Conference on Cardiovascular Disease Prevention. Circulation 2000; 102: 3137–3147 [DOI] [PubMed] [Google Scholar]
- 5. Centers for Disease Control and Prevention, National Institutes of Health. Healthy People 2010: Focus Area 12: Heart Disease and Stroke. Available at http://www.cdc.gov/cvh/hp2010/objectives.htm Accessed March 1, 2004.
- 6. Third Report of the National Cholesterol Evaluation Program (NCEP) Expert Panel on Detection , Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Available at: http://www.nhlbi.nih.gov/guidelines/cholesterol. Accessed March 20, 2004.
- 7. Ghosh J, Weiss MB, Kay RH, Frishman WH: Diabetes mellitus and coronary artery disease: Therapeutic considerations. Heart Dis 2003; 5: 119–128 [DOI] [PubMed] [Google Scholar]
- 8. Reaven G: Metabolic syndrome: Pathophysiology and implications for management of cardiovascular disease. Circulation 2002; 106: 286–288 [DOI] [PubMed] [Google Scholar]
- 9. Grundy SM: Obesity, metabolic syndrome, and coronary atherosclerosis. Circulation 2002; 105: 2696–2698 [DOI] [PubMed] [Google Scholar]
- 10. Jones DW, Chambless LE, Folsom AR, Heiss G, Hutchinson RG, Sharrett AR, Szklo M, Taylor HA Jr: Risk factors for coronary heart disease in African Americans: The Atherosclerosis Risk in Communities study, 1987‐1997. Arch Intern Med 2002; 162: 2565–2571 [DOI] [PubMed] [Google Scholar]
- 11. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group : The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs. usual care: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT‐LLT). J Am Med Assoc 2002; 288: 2998–3007 [DOI] [PubMed] [Google Scholar]
- 12. Nelson K, Norris K, Mangione CM: Disparities in the diagnosis and pharmacologic treatment of high serum cholesterol by race and ethnicity: Data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2002; 162: 929–935 [DOI] [PubMed] [Google Scholar]
- 13. American Heart Association Statistical Fact Sheet‐Risk Factors : High Blood Pressure. American Heart Association, 2004. [Google Scholar]
- 14. Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D: Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988‐1991. Hypertension 1995; 25: 305–313 [DOI] [PubMed] [Google Scholar]
- 15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. J Am Med Assoc 2003; 289: 2560–2572 [Google Scholar]
- 16. O'Connor PJ: Overcome clinical inertia to control systolic blood pressure. Arch Intern Med 2003; 163: 2677–2678 [DOI] [PubMed] [Google Scholar]
- 17. Jones MA, Schlenk EA, Kitutu JM, Sereika SM, Doswell WM, Dunbar‐Jacob J: Ethnic differences in adherence to antihypertensive medications: A prospective study (abstr 1769). Circulation 2003; 108 (suppl IV): IV‐381 [Google Scholar]
- 18. Cooper RS, Simmons BE, Castaner A, Santhanam V, Ghali J, Mar M: Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed. Am J Cardiol 1990; 65: 441–445 [DOI] [PubMed] [Google Scholar]
- 19. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229–234 [DOI] [PubMed] [Google Scholar]
- 20. Stamler J, Vaccaro O, Neaton JD, Wentworth D: Diabetes, other risk factors, and 12‐year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434–444 [DOI] [PubMed] [Google Scholar]
- 21. Centers for Disease Control and Prevention (CDC) : Prevalence of diabetes and impaired fasting glucose in adults—United States, 1999‐2000. MMWR Morb Mortal Wkly Rep 2003; 52: 833–837 [PubMed] [Google Scholar]
- 22. American Heart Association Statistical Fact Sheet‐Risk Factors : Diabetes Mellitus. American Heart Association, 2004. [Google Scholar]
- 23. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004; 291: 335–342 [DOI] [PubMed] [Google Scholar]
- 24. Bonds DE, Zaccaro DJ, Karter AJ, Selby JV, Saad M, Goff DC Jr: Ethnic and racial differences in diabetes care: The Insulin Resistance Atherosclerosis Study. Diabetes Care 2003; 26: 1040–1046 [DOI] [PubMed] [Google Scholar]
- 25. El‐Kebbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phillips LS: Association of younger age with poor glycemic control and obesity in urban African Americans with type 2 diabetes. Arch Intern Med 2003; 163: 69–75 [DOI] [PubMed] [Google Scholar]
- 26. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. J Am Med Assoc 2002; 287: 356–359 [DOI] [PubMed] [Google Scholar]
- 27. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999‐2000. J Am Med Assoc 2002; 288: 1723–1727 [DOI] [PubMed] [Google Scholar]
- 28. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity‐related health risk factors, 2001. J Am Med Assoc 2003; 289: 76–79 [DOI] [PubMed] [Google Scholar]
- 29. Brancati FL, Kao WH, Folsom AR, Watson RL, Szklo M: Incident type 2 diabetes mellitus in African American and white adults: The Atherosclerosis Risk in Communities Study. J Am Med Assoc 2000; 283: 2253–2259 [DOI] [PubMed] [Google Scholar]
- 30. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Metabolic syndrome with and without C‐reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003; 108: 414–419 [DOI] [PubMed] [Google Scholar]
- 31. Ninomiya JK, L'Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS: Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004; 109: 42–46 [DOI] [PubMed] [Google Scholar]
- 32. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle‐aged men. J Am Med Assoc 2002; 288: 2709–2716 [DOI] [PubMed] [Google Scholar]
- 33. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683–689 [DOI] [PubMed] [Google Scholar]
- 34. Centers for Disease Control and Prevention (CDC) : Declining prevalence of no known major risk factors for heart disease and stroke among adults‐United States, 1991‐2001. MMWR Morb Mortal Wkly Rep 2004; 53: 4–7 [PubMed] [Google Scholar]
- 35. Greenlund KJ, Zheng ZJ, Keenan NL, Giles WH, Casper ML, Mensah GA, Croft JB: Trends in self‐reported multiple cardiovascular disease risk factors among adults in the United States, 1991‐1999. Arch Intern Med 2004; 164: 181–188 [DOI] [PubMed] [Google Scholar]
- 36. Sharma S, Malarcher AM, Giles WH, Myers G: Racial, ethnic and socioeconomic disparities in the clustering of cardiovascular disease risk factors. Ethn Dis 2004; 14: 43–48 [PubMed] [Google Scholar]
- 37. Hall WD: Representation of blacks, women, and the very elderly (aged ≥ 80) in 28 major randomized clinical trials. Ethn Dis 1999; 9: 333–340 [PubMed] [Google Scholar]
- 38. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, Black HR, Hamilton BP, Holland J, Nwachuku C, Papademetriou V, Probstfield J, Wright JT Jr, Alderman MH, Weiss RJ, Piller L, Bettencourt J, Walsh SM: ALLHAT Collaborative Research Group: Success and predictors of blood pressure control in diverse North American settings: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALL‐HAT). J Clin Hypertens (Greenwich) 2002; 4: 393–404 [DOI] [PubMed] [Google Scholar]
- 39. Jha AK, Varosy PD, Kanaya AM, Hunninghake DB, Hlatky MA, Waters DD, Furberg CD, Shlipak MG: Differences in medical care and disease outcomes among black and white women with heart disease. Circulation 2003; 108: 1089–1094 [DOI] [PubMed] [Google Scholar]